PHARMACIE DANIEL

Sambreville ·KBO/BCE: BE 0467.947.004

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-06-2025	31 d early	2025-00232603
31-12-2023	31-07-2024	03-07-2024	28 d early	2024-00222287
31-12-2022	31-07-2023	29-06-2023	32 d early	2023-00200971
31-12-2021	31-07-2022	29-06-2022	32 d early	2022-20148762
31-12-2020	31-07-2021	28-06-2021	33 d early	2021-30100522
31-12-2019	31-07-2020	29-06-2020	32 d early	2020-22700205
31-12-2018	31-07-2019	29-07-2019	2 d early	2019-40800482
31-12-2017	31-07-2018	24-07-2018	7 d early	2018-37100514
31-12-2016	31-07-2017	06-07-2017	25 d early	2017-29300161
31-12-2015	31-07-2016	30-06-2016	31 d early	2016-25400291

Metric	This company	Sector median	Position in the sector
Solvency	-144.3%	20.4%	better than 7% of 6698 sector peers
Net result	€-5k	€4k	better than 24% of 6678 sector peers
Equity	€-415k	€16k	better than 5% of 6712 sector peers
Gross operating margin	€59k	€24k	better than 70% of 6657 sector peers
Staff costs	€42k	€33k	higher than 58% of 3035 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€288k
Fixed assets	21/28	€223k
Tangible fixed assets	22/27	€223k
Financial fixed assets	28	€88
Current assets	29/58	€64k
Stocks & contracts in progress	3	€46k
Amounts receivable within one year	40/41	€15k
Investments	50/53	€88
Cash & bank	54/58	€4k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€288k
Equity	10/15	€-415k
Contributions / capital	10/11	€50k
Accumulated profits (losses)	14	€-465k
Amounts payable	17/49	€703k
Amounts payable after one year	17	€0
Amounts payable within one year	42/48	€703k
Trade debts payable within one year	44	€28k
Income statement
Gross operating margin	9900	€59k
Operating result	9901	€-864
Financial income	75	€93
Financial charges	65	€4k
Result before taxes	9903	€-5k
Net result for the period	9904	€-5k
Result to be appropriated	9905	€-5k

Summary